A recent Politico report published Monday identified that Europe faces a renewed tobacco crisis. According to the World Health Organization (WHO), 24.1 percent of Europeans aged 15 and older use tobacco, which is now the highest global rate. At the same time, youth vaping is rising, with about 7 percent of 13 to 15-year-olds reporting e-cigarette use. In response, European policymakers are considering steep new excise taxes on vapes and other nicotine products. While taxation has been a traditional tool for curbing smoking, it is a blunt instrument. A more balanced and practical approach exists in tobacco harm reduction (THR) policies that protect youth through robust age restrictions while enabling adults who smoke to switch to demonstrably less harmful products.

THR reframes tobacco control from a moral prohibition to a pragmatic risk reduction approach. For the 1.2 billion people worldwide who smoke, immediate abstinence is rarely achievable. The scientific consensus now holds that nicotine, while addictive, is not the primary cause of tobacco-related disease; the main driver is combustion. As the National Academies of Sciences, Engineering, and Medicine concluded, e-cigarette aerosol exposes users to substantially fewer toxicants than cigarette smoke.

Scientific evidence reinforces these constructs. Research has shown that e-cigarettes doubled quit rates compared to nicotine replacement therapy with 18 percent of smokers achieving abstinence at one year, versus 9 percent in the group that received nicotine replacement therapy. Population data from the United Kingdom suggest that smokers who fully switch experience markedly improved respiratory outcomes. If adopted at scale, such substitution could avert millions of premature deaths.

Critics often argue that e-cigarettes attract adolescents to nicotine. Youth protection is vital, yet the evidence does not support a widespread “gateway effect.” A 2022 study reported no consistent causal link between e-cigarette experimentation and later smoking among never-smokers once shared risk factors were controlled. More recent reviews show that youth vaping initiation is primarily driven by flavor curiosity and peer influence, not pharmacologic dependence. The challenge for policymakers is therefore to isolate adult harm reduction benefits from youth risk through targeted regulation rather than broad restrictions that punish adult smokers seeking safer options.

Taxation remains central to the WHO Framework Convention on Tobacco Control, reducing combustible use by roughly 4 percent for every 10 percent price increase. However, equal-tax approaches for cigarettes and e-cigarettes are counterproductive. U.S. data show that when e-cigarette taxes rise, youth vaping declines modestly but cigarette use increases—a dangerous substitution effect and an unnatural progression from e-cigarettes to cigarette use. Excessive taxation also disproportionately burdens low-income adults, widening health disparities. Meanwhile, illicit-market trade undermines enforcement: In New York, more than half of all cigarettes sold are illicit. In short, taxation can suppress consumption of the most harmful products, but when applied indiscriminately, it can reinforce the most dangerous nicotine consumption mechanism: combustion.

A more effective model comes from the United States’ Tobacco 21 (T21) law, which raised the minimum purchase age for tobacco and nicotine products to 21 nationwide. Implemented in 2019, T21 combines strict retailer licensing, mandatory identification checks, and vigorous enforcement. Early results are compelling. Within a year of enactment, youth reports of “easy access” to tobacco products fell, and adolescent smoking initiation declined. National modeling projects that full enforcement could prevent more than 500,000 premature deaths in the United States by 2100. Notably, these gains occurred without restricting adult access to regulated harm reduction alternatives like the WHO is proposing.

The WHO and European Union can adapt this proven framework through three coordinated actions:

Together, these measures create a dual-protection model: keeping nicotine away from youth while providing safer pathways for adults who would otherwise continue smoking. 

Europe’s public-health imperative is clear. Heavy taxation may satisfy political optics, but it risks entrenching inequalities and sustaining combustible use. A THR strategy anchored in robust age restrictions offers a more equitable and effective route. By embracing evidence-based regulation, protecting youth through enforcement, while empowering adults to switch, the bloc can cut tobacco-related deaths dramatically without repeating the mistakes of prohibition. Harm reduction is not leniency; it is sound, compassionate policy grounded in science.